share_log

HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $12

HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $12

HC Wainwright & Co.维持对Allogene Therapeutics的买入,将目标价下调至12美元
Benzinga ·  2023/11/15 07:38

HC Wainwright & Co. analyst Robert Burns maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and lowers the price target from $23 to $12.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持Allogene Therapeutics(纳斯达克股票代码:ALLO)的买入,并将目标股价从23美元下调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发